East Providence, RI, United States of America

A Raymond Frackelton, Jr


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 109(Granted Patents)


Company Filing History:


Years Active: 1985

Loading Chart...
1 patent (USPTO):Explore Patents

Title: A Raymond Frackelton, Jr.: Innovator in Monoclonal Antibody Production

Introduction

A Raymond Frackelton, Jr. is a notable inventor based in East Providence, RI (US). He has made significant contributions to the field of biological and medical research through his innovative work on monoclonal antibodies. His research has the potential to impact the diagnosis and treatment of various diseases, including certain cancers.

Latest Patents

Frackelton holds a patent for the "Production and use of monoclonal antibodies." This patent describes a hybridoma cell line that secretes monoclonal antibodies, which serve as a high titer, reproducible biological reagent. These antibodies are useful in biological and medical research for isolating and identifying phosphotyrosine-containing proteins. The antibodies have demonstrated affinity for a variety of molecules containing o-phosphotyrosine residues and were prepared using a synthetic analog, p-azobenzyl phosphonate (ABP), covalently linked to a carrier protein as the antigen. He has 1 patent to his name.

Career Highlights

Frackelton's career is marked by his dedication to advancing scientific knowledge and improving diagnostic methods. His work has been instrumental in the development of tools that enhance research capabilities in the medical field.

Collaborations

Throughout his career, Frackelton has collaborated with esteemed colleagues, including Herman N Eisen and Alonzo H Ross. These collaborations have further enriched his research and contributed to the advancement of the field.

Conclusion

A Raymond Frackelton, Jr. is a distinguished inventor whose work in monoclonal antibody production has the potential to revolutionize medical research and diagnostics. His contributions continue to pave the way for advancements in understanding and treating diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…